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Dorsal root ganglia (DRGs) are clusters of sensory neurons that transmit the sensory information from the
periphery to the central nervous system, and satellite glial cells (SGCs), their supporting trophic cells. Sensory
neurons are pseudounipolar neurons with a heterogeneous neurochemistry reflecting their functional features.
DRGs, not protected by the blood brain barrier, are vulnerable to stress and damage of different origin (i.e.,
toxic, mechanical, metabolic, genetic) that can involve sensory neurons, SGCs or, considering their intimate
intercommunication, both cell populations. DRG damage, primary or secondary to nerve damage, produces a
sensory peripheral neuropathy, characterized by neurophysiological abnormalities, numbness, paraesthesia and
dysesthesia, tingling and burning sensations and neuropathic pain. DRG stress can be morphologically detected
by light and electron microscope analysis with alterations in cell size (swelling/atrophy) and in different sub-
cellular compartments (i.e., mitochondria, endoplasmic reticulum, and nucleus) of neurons and/or SGCs. In
addition, neurochemical changes can be used to portray abnormalities of neurons and SGC. Conventional
immunostaining, i.e., immunohistochemical detection of specific molecules in tissue slices, can be employed
to detect, localize and quantify particular markers of damage in neurons (i.e., nuclear expression of ATF3) or
SGCs (i.e., increased expression of GFAP), markers of apoptosis (i.e., caspases), markers of mitochondrial suf-
fering and oxidative stress (i.e., 8-OHdG), markers of tissue inflammation (i.e., CD68 for macrophage infiltra-
tion) etc. However classical (2D) methods of immunostaining disrupt the overall organization of the DRG, thus
resulting in the loss of some crucial information. Whole-mount (3D) methods have been recently developed to
investigate DRG morphology and neurochemistry without tissue slicing, giving the opportunity to study the
intimate relationship between SGCs and sensory neurons in health and disease. Here, we aim to compare clas-
sical (2D) vs whole-mount (3D) approaches to highlight “pros” and “cons” of the two methodologies when
analysing neuropathy-induced alterations in DRGs. 
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Supplementary Video 1. Representative 3D reconstruction of a whole-mount mouse DRG in which CGRP+
neurons (blue) and SGCs (GS+, red) are immunolabelled. 
Supplementary Video 2. Representative 3D reconstruction of a whole-mount mouse DRG showing CGRP+
(blue) and IB4+ (yellow) sensory neurons.
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Introduction
Dorsal root ganglia (DRGs) are clusters of sensory neurons
and satellite glial cells (SGCs) in intimate relationships. They are
particularly vulnerable to stress of different origin and intensity
due to the lack of the blood brain barrier in the peripheral nervous
system. Peripheral neuropathy is the most common disorder of the
peripheral nervous system in adults with increasing prevalence and
heterogeneous causes. Since no effective treatment is available for
patients suffering from this debilitating condition, the identifica-
tion of molecular pathways is mandatory to elucidate mechanisms
of disease and identify novel targets for neuroprotective therapies.
Despite the classical immunostaining is a valuable analysis to go
insight the morphostructural features as well as neurochemistry of
DRG damage, new innovative whole-mount analysis can be valid
alternative approaches for studying the 3D morpho-functional
abnormalities in sensory neurons, SGCs and in their intimate
exchanges. In the following paragraphs, we will: i) recall the dis-
tinctive anatomical features of DRGs; ii) revise the common
approaches for investigating DRG alterations in peripheral neu-
ropathies; and iii) introduce recently developed whole-mount
methodologies. Advantages and disadvantages of the different
techniques will be discussed.
Anatomy of the dorsal root ganglia
Sensory neurons
Primary sensory neurons of the DRGs are the first-order neu-
rons along the pathway conveying sensory information from the
periphery to the central nervous system. They are pseudounipolar
neurons with a single axon that bifurcates in a branch projecting to
the periphery and a branch projecting to the spinal cord. Sensory
neurons detect and transduce information from a variety of special-
ized receptors, such as nociceptors, mechanoreceptors, and propri-
oceptors.1
Several classifications of sensory neurons have been proposed
over the years based on: the cell body size, the neurochemical phe-
notype, the functional physiological properties, the degree of
myelination of peripheral branches and the pattern of central termi-
nation in the spinal dorsal horn.2-4
Based on the cell body diameter, sensory neurons can be sub-
divided in small-, medium- and large-sized neurons.
Small-sized DRG neurons (10-30 µm in diameter) give rise to
small diameter unmyelinated C fibers that display a slow conduc-
tion velocity and mostly convey noxious and/or thermal stimuli to
the CNS.5 Based on the phenotype, small neurons can be further
split into peptidergic or non-peptidergic neurons depending on the
expression of transmitter neuropeptides.3Peptidergic nociceptors
express one or more neuropeptides, such as the calcitonin gene-
related peptide (CGRP),6-10 substance P (SP),9-11 somatostatin
(SST).9,12 Further subdivisions of peptidergic neurons have been
proposed based on the neurotrophic content (i.e., BDNF and
GDNF).13 Non-peptidergic nociceptors typically bind the isolectin
B4 from Griffonia simplicifolia (IB4) and are immunoreactive to
the LA4 antibody.14 These neurons also express GDNF receptors
RET, GFRα1, GFRα29,15,16 and the purinergic receptor P2X3.17
Medium-sized DRG neurons (30-50 µm in diameter) are main-
ly nociceptors and give rise to fine myelinated Aδ-type primary
afferent fibers displaying faster conduction velocity as compared
to C fibers.1 These neurons may express the neuropeptide
CGRP,6,18 but do not contain binding sites for IB4. Large-sized
DRG neurons (>50 µm in diameter) give rise to heavily myelinated
Aβ-type primary afferent fibers displaying fast conduction veloci-
ties. Large neurons typically encode touch or proprioception and
express the neurofilament NF200.19
The continuous discovery of novel neurochemical and func-
tional markers,4 as well as the application of new molecular tech-
niques and single-cell proteomics to DRG neurons20,21 have identi-
fied additional neuronal phenotypes, including C-fiber small neu-
rons that do not express peptides and do not bind IB4, but express
the vesicular glutamate transporter type 3 (VGLUT3), the tyrosine
hydroxylase (TH),22-24 the chemokine-like protein TAFA425,26 and
the Gαi-interacting protein GINIP.23,27,28
Functionally, the different neuronal phenotypes have been
associated with specific sensory modalities. Indeed, the thermal
receptor TRPV1 is mostly found in peptidergic neurons,29 while
mechanotransducers such as PIEZO130 and TACAN31 are chiefly
found in non-peptidergic neurons. On the other hand, recent evi-
dence obtained by in vivo calcium imaging have demonstrated that
most small sensory neurons are polymodal.32 In addition, impor-
tant species differences could be observed in phenotypic marker
expression. For instance, the vanilloid receptor TRPV1 is
expressed in both peptidergic and non-peptidergic sensory neurons
in rat,33-37 and a small population of non-peptidergic neurons
expressing TRPV1 has also been reported in mice.23,37-39 In a simi-
lar manner, GINIP is exclusively expressed in non-peptidergic
neurons in mouse,23,39,40 while it has been also described in pep-
tidergic neurons in rat.28 Even in human DRGs, the neurochemical
boundaries between peptidergic and non-peptidergic populations
of sensory neurons are not as sharp as originally described in
rodents.41 Thus, neuronal phenotypes may be important, but not
sufficient, for defining the role of DRG neuronal populations in
sensory encoding. Indeed, several lines of evidence strongly indi-
cate that a crucial role in the definition of specific sensory modal-
ities is played by the central arrangement of primary afferent pro-
jections in the spinal dorsal horn.42,43
Satellite glial cells
Satellite glial cells (SGCs) of the DRGs are a group of perineu-
ronal cells that envelop cell bodies of sensory neurons providing
metabolic support and influencing neuronal function.44-47 SGCs
were described as cells with a relatively large nucleus and perineu-
ronal processes.46 Then, subsequent investigations led to identify
SGCs as laminar cells with a flattened glial sheath surrounding
sensory neurons.44 Specifically, several SGCs surround a single
neuron forming a morphological and functional unit,44,48 which is
separated from adjacent SGCs/neurons units by connective tis-
sue.44,46,47 The number of SGCs rises with the increase of the neu-
ron’s volume.46,49 In some species such as lizard, rat and rabbit, it
has been described that a common glia sheet could wrap different
neurons forming a “cluster”, mostly in young animals.47,50 In these
units, glial and neuronal membranes are in close apposition, with a
distance of 15-20 nm.46 The glial layer could also be discontinuous
leading to a direct contact between membranes of two adjacent
neurons.47,51
SGCs around DRG neurons are connected each other by gap
junctions consisting of protein connexins46 and the most abundant
so far described in SGCs are Cx43 and Cx32.52,53 Moreover, SGCs
show dye coupling as observed after injection with Lucifer
yellow.54 These features clearly indicate that SGCs carry out sev-
eral important functions for DRG homeostasis, providing trophic
and mechanical support for sensory neurons, regulating ion con-
centration, diffusion and trafficking of molecules between
neurons.48
SGCs can be identified by the expression of several glial mark-
ers such as glutamine synthetase,51,55 GFAP,44,56,57 S-100,58,59
vimentin,58 Cx42,53 Kir4.1 potassium channels60 and glutamate
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transporters.45,61 In particular, Nascimento and colleagues58 have
postulated the existence of a heterogeneous population of SGCs in
DRGs after the observation that the expression pattern of S-100
and vimentin in SGCs is related to the neuron size they enwrapped.
The heterogeneity of SGCs is consistent with our recent observa-
tion that different neuron-glia arrangements can be found in DRG
for specific neuronal phenotypes.51
Due to the peculiar neuron-glia arrangement, an increasing
number of studies have investigated the potential impact of trans-
glial communication in shaping sensory transmission. The seminal
work of Devor and Wall62 demonstrated electrical coupling
between DRG neurons arranged in small clusters. Subsequently,
Rozansky and colleagues63,64 showed that the spread of excitation
from stimulated sensory neurons to adjacent neurons is mediated
by the interposed SGCs. The authors defined this type of neuron-
glia-neuron communication as “sandwich synapse”. Following a
train of stimulation, sensory neurons signal to the associated SGCs
via purinergic signaling (i.e., through P2Y2 receptors).64 In turn,
activated SGCs depolarize adjacent neurons via glutamate release
and NMDA receptor activation64 or nitric oxide.65 The electrical
coupling between SGCs via gap junctions may additionally ampli-
fy the signal allowing the recruitment of several adjacent neurons.
Conventional approaches for morpho-functional
analysis of DRGs during peripheral neuropathy 
The damage of DRG determines the establishment of a sensory
neuropathy, which can be due to a primary damage of sensory neu-
rons and/or SGCs (for example after platinum-derived chemother-
apy) or to a damage secondary to peripheral nerve injury (for
example after peripheral nerve trauma, as compression or transec-
tion). Patients with sensory neuropathy may have neurophysiolog-
ical abnormalities in peripheral nerves, numbness, paraesthesia
and dysesthesia, proprioceptive ataxia, tingling and burning sensa-
tions, widespread areflexia, neuropathic pain. Several are the caus-
es of peripheral neuropathy, as autoimmune disease (e.g., Guillain-
Barre syndrome), diabetes, infections, inherited disorders (e.g.,
Charcot Marie Tooth), solid and blood tumors, alcoholism, expo-
sure to toxic substances (drugs as chemotherapy, poisons, as heavy
metals and industrial chemicals), traumas or pressure of the periph-
eral nerves and vitamin deficiencies (B-1, B-6 and B-12, E). The
features of DRG abnormalities can be determined by the nature of
the insult and can involve sensory neurons, SGCs or, considering
their intercommunication, both cell populations. Traditional
immunohistochemical/histological approaches on DRG sections at
both optical and ultrastructural level have been extensively used to
address both morphological and molecular changes in pathological
conditions. In the following paragraphs, we will review the main
applications of these approaches in painful peripheral neuropathy. 
Alterations in DRG sensory neurons
Depending on the cause and exposure extension, different cel-
lular compartments can be damaged in sensory neurons. Electron
microscopy observations, for example, revealed mitochondria
swelling, dilatation in the cisternae of rough endoplasmic reticu-
lum and Golgi complex, microtubule and neurofilament disarrang-
ing after chemical exposure. Moreover, neuronal enlargement,
rounding of the cytoplasmic membrane, eccentric displacement of
the nucleus and nucleolus, loss of Nissl substance can be evi-
dent.66,67
Neuronal suffering can lead to neuronal death through differ-
ent pathways that can be biochemically and/or morphologically
determined (autophagy, necrosis, apoptosis). Morphological fea-
tures of necrotic sensory neurons involve cell swelling and degen-
eration of cytoplasmic organelles under the action of cellular lytic
enzymes (lipases, proteases, endonucleases) that produce alter-
ations in nuclear and cellular membranes, resulting in cellular dis-
gregation and recruitment of inflammatory cells. Depletion of ATP
can influence a progressive decrease of cellular processes and
organelles’ failure.68
By contrast, apoptosis requires energy and protein synthesis to
proceed and is regulated by several specific molecules that orches-
trate the cascade of apoptotic events (i.e., caspases).
Morphological features of apoptotic sensory neurons include cyto-
plasmic shrink, irreversible fragmentation and condensation of
chromatin (piknosis) with intact nucleus. Organelles and plasma
membranes are unaltered, thus avoiding an inflammatory response.
Neurotoxic platinum drugs as cisplatin and oxaliplatin, employed
in chemotherapy regimens against several solid tumors (i.e., testis,
lung, ovarian, colon cancers), produce a “neuronopathy” with
DRG sensory neurons damage69 and triggering of apoptotic path-
ways (Figure 1). 
In diabetic sensory neuropathy, peripheral microvascular
injury associated with the cellular consequences of high glucose
levels in the blood leads to the formation of advanced glycation
end products in neurons and increased production of reactive oxy-
gen species (ROS) that alter neuronal metabolism and function.70-
74 Morphological and quantitative evaluations on DRG of animals
affected by experimental diabetic neuropathy showed somatic
atrophy75 and a disorganized neuronal structure with cellular
shrinkage and nuclear and nucleolar blurring with the formation of
vacuolar-like structure in the cytoplasm. A computer-assisted
quantitative analysis of Nissl/stained neurons also showed an evi-
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Figure 1. Examples of neuronal alterations detected by standard
histological procedures on DRG sections after exposure to neuro-
toxic chemotherapy (cisplatin): nuclear condensation and frag-
mentation can be observed in DRG sensory neurons exposed to
cisplatin in vitro (a, Hoechst staining). Cisplatin determines an
increased incidence of multiple nucleoli in vivo (b) as well as
alterations in nucleolar segregation of granular and fibrillar com-
ponents (c) in DRG sensory neurons compared to non-treated
control (d-e).
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dent neuronal loss in the DRG of diabetic neuropathic rats.76
The morphofunctional changes of some subpopulations of sen-
sory neurons can be relevant also during neuropathic pain. In the
onset of neuropathic pain, peripheral nerve injury increases the
excitability of sensory neurons in DRGs leading to spontaneous
activation and discharge (hyperexcitability), then involving upper
central circuits. Neurochemical properties can be used to identify
those neurons who are involved in nociception and are altered due
to the establishment of neuropathic pain by immunostaining. For
instance, the capsaicin receptor TRPV177-79 can be activated and/or
sensitized by mechanical stress, noxious heat, protons, and other
endogenous compounds released following tissue injury. TRPV1
activation determines neuronal depolarization, which causes the
release of sensory neuropeptides such as CGRP and SP from
peripheral and central nerve terminals which in turns enhance the
sensitization of nociceptor through the interaction with their effec-
tor cell receptors.80 As previously stated, the presence of TRPV1 is
restricted to small- and medium-sized neurons with reactivity in
both peptidergic (CGRP+) and non-peptidergic (CGRP-) sensory
neurons.33,81 In DRG of neuropathic rats in which neurotoxic
chemotherapy determined mechanical and thermal nociception,
TRPV1+ neurons were increased and most TRPV1+ neurons had
a small-medium size. A similar pattern has been described for
CGRP with a decrease in the co-localization with TRPV1.82
Alterations in DRG, SGCs and in neuron-SGCs
crosstalk
Although the scenario is huge and conditions variable, SGCs
seem to be generally less susceptible than sensory neurons to sev-
eral kinds of injury. In many cases, the alterations of SGCs do not
seem to be due to a direct effect of exogenous insults, rather to the
response of these cells to alterations occurring in sensory neurons.
Consequently, in most cases, SGCs damage can be described as
secondary to sensory neuron damage. The general response of
SGCs to toxic-induced neuronal as well as axonal injury is the
increase in number (i.e., gliosis) after mitotic division83-85 to meet
the increased metabolic requirements of damaged neurons to
attempt axonal regeneration. After this, SGCs undergo a series of
structural modifications involving cytoplasmic organelles and
some metabolic changes in enzymatic activities. Evident sign of
SGCs activation is an increased expression of GFAP, S100, trans-
forming growth factors, neurotrophins, receptors, cell adhesion
molecules, interleukins, tumor necrosis factor.57,59,86-89 Other
changes that occur in SGCs after neuronal damage are a marked
increase in gap junctions that connect neighbouring SGCs and the
formation of bridges from previously separated perineuronal
sheats.90 In physiological conditions, SGCs are connected within
the same perineuronal sheats, while in pathological circumstances,
the formation of molecular bridges between different perineuronal
sheats and the increased gap junction lead to an enhanced coupling
among SGCs providing long-distance interconnections between
them. These plastic changes in SGCs are trophic for damaged neu-
rons in responding to stress.91
Considering that SGCs are the only cells in direct contact with
sensory neurons and fundamental in regulating neuronal home-
ostasis and excitability, they play a role in the development and
maintenance of neuropathic pain. Their changes are secondary to
nervous alterations, after activation of injured neurons-SGCs sig-
nalling pathways. Several molecular mechanisms have been pro-
posed to explain how SGCs can be activated and react to nerve
injury and sensory neurons’ hyperexcitability acting on the devel-
opment and maintenance of neuropathic pain. An example is the
activation of purinergic receptors on SGCs after ATP release by
neurons: this can cause the release of proinflammatory cytokines
by SGCs that in turns enhance neuronal excitability.86
Since gap junctions between SGCs increase in number and
coupling after nerve injury, they can be involved in the generation
and maintenance of neuropathic pain. The evidence came from the
ability of gap junction blockers in restoring neuronal excitability
and reducing pain in several pain models including chemotherapy
treatment.92,93 Several papers also postulated that the expression of
connexins, the proteins that assemble together forming the gap
junctions, can be augmented in painful pathological condi-
tions.48,91,94 Morpho-structural abnormalities are also evident in
SGCs of animals chronically treated with chemotherapy treatment
(bortezomib or cisplatin): they show clear cytoplasmic vacuolation
and hypertrophy of the cytoplasm, invaginations of the plasma-
membrane and altered chromatin segregation, as well as increased
proliferation (gliosis).69,95,96
GFAP expression increment, because of gliosis, is widely used
as a marker of neuronal damage in both CNS and PNS.97-101 For
instance, some authors have observed an increment in the number
of GFAP+ SGCs surrounding stressed neurons (therefore ATF3
positive) in animal models of arthritis evidencing a direct relation-
ship between neuronal insult and SGCs activation.99,102 On the
other hand, Barragán-Iglesias and colleagues103 and Peters and col-
leagues104 have observed a strong ATF3 positivity also on GFAP+
SGCs at late stages of both diabetic- and paclitaxel-induced
peripheral neuropathy animal models.
In addition, Peters and colleagues104 reported the presence of
CD68+ macrophages in rat DRGs and sciatic nerves after 6 days of
paclitaxel treatment that, besides SGCs activation, represents as
well a sign of tissue damage. Painful neuropathies induced by
paclitaxel activate the expression of monocyte chemotactic protein
1 (MCP-1) triggering macrophage infiltration in the DRG, which
cells, in turn, express inflammatory cytokines.105,106 Interestingly,
this event seems to happen in concomitance with the onset of the
neuropathy, suggesting an important role of CD68+ macrophages
in the development of the pathology in DRG. This observation is
validated, somewhat, by Zhang and colleagues106 who describe that
the administration of anti-MCP-1 neutralizing antibodies reduced
macrophage infiltration in the DRG and prevented the develop-
ment of mechanical hypersensitivity (paw withdrawal threshold) in
the paclitaxel treated animals. Therefore, macrophage infiltration
in DRG during painful neuropathy, more than simply helping
remove degenerating neuronal debris and contribute to subsequent
regeneration, as previously suggested,106,107 seems to contribute to
the onset of the pathology and maintenance of chronic pain.106,108
DRG insult can also trigger the expression of pro- and anti-
apoptotic molecules. In fact, in a 10-month rat chronic model of
diabetes, even though Kamiya and colleagues109 observed an incre-
ment in pro-apoptotic protein expression (caspase-3) against a
decrement (HSP70) or no alteration (Bcl-xL, HSP27) in the anti-
apoptotic ones, they did not discern the presence of apoptotic cells
(DRG neurons, mitochondria or endoplasmic reticulum did not
show any morphological alteration). DRG neurons seemed to be
kept in a sustained stressed state. Only the Golgi apparatus
appeared highly vacuolized and fragmented, and this could have
been one of the reasons for the progressive DRG cells loss in these
animals.109 On the other hand, in chronic (12 months) experimental
diabetic rats several authors reported apoptosis (Caspase-3 and
TUNEL positive) as soon as 1 and 3 months after streptozotocin
treatment together with the presence of swelled mitochondria with
disrupted inner cristae structure and condensation of chro-
matin.74,110 It has also been implied the existence of a direct associ-
ation between oxidative injury (8-OHdG expression) and neuronal
apoptosis in these animals.74 Mitochondria of DRG neurons also
happen to be a target in platinum-based peripheral neuropathies as
demonstrated in vitro111 and in vivo112 and when damaged ROS rise
and calcium homeostasis becomes altered.113,114 In fact, platinum-
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based drugs form DNA adducts not only in the nucleus of the DRG
neurons,96,115,116 but also within mitochondrial DNA where pro-
found functional modifications such as replication and transcrip-
tion interference take place, leading to a progressive mitochondrial
vacuolization and degradation.117 Moreover, Corsetti and col-
leagues118 described mitochondrial and cytoplasmic alterations
also in SGCs after cisplatin treatment and propose that neuronal
damage is subsequent to SGCs damage, therefore attributing to
SGCs a main role on platinum-based peripheral neuropathies.
Another marker for SGCs functional changes under stress con-
ditions is Connexin 43. Its expression in gap junctions increases in
SGCs after taxane treatment,93 indicating an increment of gap junc-
tion-mediated coupling between SGCs that contributes to the
establishment of chronic pain as reported in different neuropathic
pain models.54,90,119,120
Moreover, SCG purinergic P2 receptors are the target of the
ATP and TNF-α released by stressed or damaged neurons that trig-
gers a gap junction-dependent Ca2+ waves between the SGCs.94,12
Interestingly, in diabetes animal models, the purinergic P2X7
receptor is upregulated in SGCs which results in a hyperexcitabil-
ity of DRG neurons.122
In keeping, peripheral neuropathy induces a variety of alter-
ations in both DRG neurons and glia and in their reciprocal inter-
actions that can be investigated by standard histological proce-
dures on DRG sections, combined with immunohistochemistry.
These classical approaches provide an effective tool to address cel-
lular and subcellular alterations and still represent the gold stan-
dard to detect neurodegenerative processes. However, these classi-
cal methods, while favoring the access to individual cell bodies,
disrupt the overall organization of the DRG, thus resulting in loss
of some crucial information. Optimizing the technical approach to
investigate the entire DRG is the necessary premise to fully evalu-
ate the impact of internal organization on function. In recent times,
innovative whole-mount methods, discussed below, have been
developed to investigate large areas of the nervous system without
slicing and allowing the evaluation of cell populations in their inti-
mate relationship, close to physiological conditions. 
Whole mount morphological approaches for
studying neuron-to-glia structural association in
DRGs
Most whole-mount 3D methods aim to convert large opaque
pieces of tissue in transparent specimens by reducing light scatter-
ing (tissue clearing methods, for review123,124). Different technical
approaches have been proposed, based on either the use of solvent
(hydrophobic methods, such as BBAB, DISCO), aqueous reagents
(hydrophilic methods, such as SeeDB), or hydrogels (such as
CLARITY).124
Initial attempts to clarify nervous tissues were chiefly based on
solvent-based approaches to solvate lipid content in the samples,
thus allowing the tissues to become translucent. Although relative-
ly easy to implement, these methods were typically hampered by
high levels of autofluorescence, incapacity to preserve endogenous
fluorescence and limited compatibility with macromolecule-based
phenotyping techniques.125 Nevertheless, hydrophobic clearing
methods have been successfully applied to certain whole-mount
preparations of peripheral sensory neurons.123 Indeed, a combina-
tion of transparency and immunophenotyping has been recently
reported in intact DRGs from both embryonic126 and adult mice.127
On the other hand, the innovative hydrogel based methods pro-
posed by Karl Deisseroth’s lab in 2013, known as CLARITY,
paved a novel path for combining whole-mount preparations and
immunostaining.128 The clearing method originally consisted in an
active lipid extraction procedure allowing the conversion of entire
pieces of brain into light-permissive macromolecule-permeable
specimens.128 Hydrogel reinforcement allows excellent transparen-
cy of the specimen (as obtained by classical hydrophobic methods)
with minimal loss of macromolecules and antigenicity.124
Moreover, unlike hydrophobic approaches, CLARITY does not
affect endogenous fluorescence and can be conveniently adopted
in transgenic animals. The initial method was, however, somehow
labored and changes have been subsequently proposed to improve
reproducibility, reducing costs, and mitigate the overall duration of
the clearing/staining protocols (see for instance, PACT, SHIELD,
PARS).129
Recently, Bernal and colleagues130 have proposed a cost-effec-
tive variation of CLARITY (inCLARITY) based on passive lipid
clearing protocol to image DRGs. The method consisted in a first
phase of hydrogel polymerization in acrylamide/bisacrylamide,
followed by a long lipid clearing phase in sodium dodecyl sulphate
(>7 days). This method was used for combining immunophenotyp-
ing of sensory neurons and retrograde fluorescent tracers. While
inexpensive and technically simple, the method requires long incu-
bation times spanning over two weeks for both clearing procedures
and antibody incubation.
In 2016, we proposed an alternative whole-mount method for
3D DRG processing without a clearing approach.131 Indeed, tissue
clearing is instrumental to minimize light scattering in large spec-
imens. However, rodent (and particularly mouse) DRGs are rela-
tively small (<1 mm) and light permissive. The main obstacle to
obtain multilayer immunostaining in entire DRGs is thus repre-
sented by antibody penetration. To overcome this problem, we pro-
posed to incubate freshly dissected DRGs with collagenase (5-10
mg/ml) to digest the connective tissue forming the DRG capsule.
Collagenase was previously used to permit patch clamp recordings
in entire rat DRGs.132,133 Indeed, we applied this approach for
recording functional properties of sensory neurons without disso-
ciating, thus preserving local anatomical interactions. After record-
ing, and following a short fixation in paraformaldehyde, DRGs
were processed for immunohistochemistry in order to phenotype
the recorded neurons. Surprisingly, we found that collagenase
treatment significantly improved antibody penetration in the
DRGs, as compared to untreated DRGs.131 Representative 3D
reconstructions are shown in  Supplementary material.
The protocol was subsequently optimized for 3D morphologi-
cal analysis and the method allowed to uncover specific spatial
arrangements of sensory neurons belonging to different cell popu-
lations.51 Namely, non-peptidergic neurons were found to form cell
clusters in which cell somata lie in close apposition, while pep-
tidergic neurons do not. In the same study, we also analyzed the
relationship between SGCs and sensory neurons taking advantage
of the possibility to analyze the contact between glia and neurons
all along the neuronal surface in whole mount-preparation (Figure
2). Interestingly, whole-mount preparation allows us to appreciate
how different neuron-glia arrangements can be detected for differ-
ent populations of sensory neurons.51
As compared to clearing-based whole-mount approaches, our
proposed protocol is fast, cost effective and highly reproducible
and can be easily combined with functional approaches (i.e.,
addressing the phenotype of recorded neurons).
Major limitations are common to all whole-mount approaches,
and specifically:
1) Technical limitations to image large 3D specimens. The
increased interest in whole-mount approaches has been accompa-
nied in recent years by a parallel development of optical systems
to see deeper in the sample, such as lightsheet microscopy and
multiphoton confocal microscopy.134 Although these devices are
becoming more and more accessible, yet standard one-photon
[page 51][European Journal of Histochemistry 2021; 65(s1):3276]
2021_s 1 Article.qxp_Hrev_master  19/10/21  09:12  Pagina 51
                             Review
scanning confocal microscopes are by far the more common set-up
found in many laboratories. The use of one-photon confocal
microscopy allows accurate 3D reconstruction of small volumes or
of restricted areas of large samples.135 This approach is suitable for
mouse DRGs as their diameter falls below the millimeter and long
working distance objectives are adequate to fully scan the speci-
men. In our study, we successfully acquired 3D images with a stan-
dard one-photon laser scanning confocal (Leica SP5).
Interestingly, a one-photon microscope was also used to image
cleared DRG by inCLARITY.130 The overall yield in terms of
image definition and thickness of 3D reconstruction are compara-
ble in the two studies thus suggesting that the major limiting factor
for Z-scanning in DRGs is not due to the use of clearing approach-
es but, rather, to the technical limitations of the optical devices.
2) Technical issues for analyzing 3D images. 3D reconstruc-
tion of biological samples is providing novel insight in the under-
standing of the organization of the nervous system. However, to
properly analyze and extract quantitative information from these
samples traditional 2D methods are limited and appropriate soft-
ware-based methods are required. To this aim, we have developed
a software (3DRG), that provides a fully-automated segmentation
of positively labeled nociceptors in whole-mount DRG prepara-
tions.136 3DRG has been conceived to characterize the sample in a
fully-automated way, allowing the visualization of identified cell
populations to highlight spatial relations. Recently, Bennett’s
group has proposed an image analysis tool (StereoMate) to devel-
op image segmentation protocols in DRGs and extract unbiased
information at the cell level.127 The tool can be combined with a
machine learning classifier to facilitate correct object recognition.
Other machine learning approaches are emerging137 and represent
a promising avenue for addressing cell-to-cell interactions in a 3D
environment.
Application of a 3D DRG approach in pathologi-
cal settings
While traditional approaches based on classical tissue slicing
techniques are still the gold standard for fine subcellular analysis
of morphological and molecular alterations in pathological DRGs
(Figure 1), yet whole-mount methods represent a powerful and
complementary alternative to explore changes in cell-to-cell rela-
tionships. Main advantages of 2D vs 3D approaches are reported in
Table 1.
We have recently applied our whole-mount technique to inter-
rogate the impact of diabetic neuropathy in altering neuron-neuron
and neuron-glia interactions.51 An example of this application and
its potentiality is shown in Figure 2. In agreement with previous
studies,98 major differences were mainly detected in the relation-
ship between SGCs and neurons. Specifically, we used our 3D
method to analyze the distribution of SGCs marker GS around
identified populations of sensory neurons, such as CGRP neurons
(blue in Figure 2 a,b). The possibility of changing the z-axis allows
to standardize GS quantification around the largest diameter of the
identified neurons, which would not be possible in standard cryo-
stat or microtome-based sections, thus making comparisons
between groups more robust. Our analysis demonstrated that GS
staining is significantly increased around CGRP+ neurons from
diabetic mice (Figure 2 c,d).
3D approaches have also been successfully applied to detect
DRG alterations following peripheral nerve injury. Indeed, whole
mount DRG preparations were successfully used to quantify the
loss of neurons in a murine model of spared nerve injury.127 A sim-
ilar result can be also obtained by standard stereological approach-
es, which are, however, time consuming and more exposed to sam-
pling errors.127
In perspective, other potential applications of 3D DRG speci-
mens in pathological conditions may include:
● analysis of DRG infiltrations of immune cells;
● structural plasticity of fluorescent-tagged populations of sen-
sory neurons (i.e., change in size or in cell-to-cell relation-
ship);
● alterations in the somatotopic organization of afferent inputs
(i.e., by retrograde labelling of sensory neurons innervating
restricted peripheral territories);
● identification of functional interaction between neighbouring
Table 1. Pros and cons of whole-mount methods vs. classical sec-
tion-based approaches.
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Figure 2. Whole-mount mouse DRG staining after collagenase
treatment. a) CGRP+ neurons (in blue) and GS+ satellite glial
cells (in red) in lumbar DRG from a control mouse; from left to
right, sequential z-stacks are shown; a viable approach for GS flu-
orescence quantitation is also represented; the intensity of GS
staining is measured across the maximum diameter along the Z-
axis of identified CGRP+ cells (coloured lines).(b) CGRP+ neu-
rons (in blue) and GS+ satellite glial cells (in red) from a diabetic
mouse. c-d) GS fluorescence intensity per pixel along the
coloured lines (distance in microns) in (a) and (b). Note the flu-
orescence peaks at the perimeter of the sensory neurons where
SGCs are located. Higher fluorescent signals are detected in dia-
betic mice (d). Scale bar: 50 µm.
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sensory neurons by using markers of neuronal activation (i.e.,
ERK1/2 phosphorylation);138
● combining functional and morphological analysis in entire
DRGs.131
Conclusions
In keeping, 3D analysis of sensory neurons is a growing and
promising method that can be adopted together with or as alterna-
tive to standard histological 2D approaches for tackling specific
questions around the impact of DRG structure on sensory function
(Table 1). The anatomical organization of the DRGs suggests that
neuron-neuron as well SGC-SGC or SGC-neuron interactions
influence neuron physiology. This “interactive” homeostasis can
be lost once the DRG are processed with tissue and/or cell prepa-
ration standard protocols for conventional morpho-functional
analysis. In the whole 3D DRG, instead, the cyto-architecture of
the organ as well as the anatomical relationship between the differ-
ent cell populations are preserved.
Acknowledgements 
We are thankful to Prof. Arianna Scuteri who kindly provided
the picture of cultured neurons tested for nuclear fragmentation.
Thanks to Fondazione Cassa di Risparmio di Torino (CRT; grant
No. RF = 2015.1690 to F.F.).
References
1. Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and
molecular mechanisms of pain. Cell 2009;139:267-84.
2. Averill S, McMahon SB, Clary DO, Reichardt LF, Priestley
JV. Immunocytochemical localization of trkA receptors in
chemically identified subgroups of adult rat sensory neurons.
Eur J Neurosci 1995;7:1484-94.
3. Lawson SN. Morphological and biochemical cell types of
sensory neurons. In: Scott SA, editor. Sensory neurons:
Diversity, development, and plasticity. New York: Oxford
University Press; 1992. p. 27-59.
4. Le Pichon CE, Chesler AT. The functional and anatomical
dissection of somatosensory subpopulations using mouse
genetics. Front Neuroanat 2014;8:21.
5. Lawson SN, Perry MJ, Prabhakar E, McCarthy PW. Primary
sensory neurones: neurofilament, neuropeptides, and conduc-
tion velocity. Brain Res Bull 1993;30:239-43.
6. Gibson SJ, Polak JM, Bloom SR, Sabate IM, Mulderry PM,
Ghatei MA, et al. Calcitonin gene-related peptide immunore-
activity in the spinal cord of man and of eight other species.
J Neurosci 1984;4:3101-11.
7. Lawson SN. Neuropeptides in morphologically and function-
ally identified primary afferent neurons in dorsal root gan-
glia: substance P, CGRP and somatostatin. Prog Brain Res
1995;104:161-73.
8. McCarthy PW, Lawson SN. Cell type and conduction veloc-
ity of rat primary sensory neurons with calcitonin gene-relat-
ed peptide-like immunoreactivity. Neuroscience 1990;34:
623-32.
9. Salio C, Ferrini F, Muthuraju S, Merighi A. Presynaptic mod-
ulation of spinal nociceptive transmission by glial cell line-
derived neurotrophic factor (GDNF). J Neurosci 2014;34:
13819-33.
10. Salio C, Lossi L, Ferrini F, Merighi A. Neuropeptides as
synaptic transmitters. Cell Tissue Res 2006;326:583-98.
11. McCarthy PW, Lawson SN. Cell type and conduction veloc-
ity of rat primary sensory neurons with substance P-like
immunoreactivity. Neuroscience 1989;28:745-53.
12. Ribeiro-da-Silva A. Ultrastructural features of the colocaliza-
tion of calcitonin gene related peptide with substance P or
somatostatin in the dorsal horn of the spinal cord. Can J
Physiol Pharmacol 1995;73:940-4.
13. Salio C, Ferrini F. BDNF and GDNF expression in discrete
populations of nociceptors. Ann Anat 2016;207:55-61.
14. Stucky CL, Lewin GR. Isolectin B(4)-positive and -negative
nociceptors are functionally distinct. J Neurosci
1999;19:6497-505.
15. Bennett DL, Michael GJ, Ramachandran N, Munson JB,
Averill S, Yan Q, et al. A distinct subgroup of small DRG
cells express GDNF receptor components and GDNF is pro-
tective for these neurons after nerve injury. J Neurosci
1998;18:3059-72.
16. Ferrini F, Salio C, Boggio E, Merighi A. Interplay of BDNF
and GDNF in the mature spinal somatosensory system and its
potential therapeutic relevance. Curr Neuropharmacol
2021;19:1225-45.
17. Bradbury EJ, Burnstock G, McMahon SB. The expression of
P2X3 purinoreceptors in sensory neurons: effects of axotomy
and glial-derived neurotrophic factor. Mol Cell Neurosci
1998;12:256-68.
18. Lawson SN, McCarthy PW, Prabhakar E.
Electrophysiological properties of neurones with CGRP-like
immunoreactivity in rat dorsal root ganglia. J Comp Neurol
1996;365:355-66.
19. Lawson SN, Harper AA, Harper EI, Garson JA, Anderton
BH. A monoclonal antibody against neurofilament protein
specifically labels a subpopulation of rat sensory neurones. J
Comp Neurol 1984;228:263-72.
20. Usoskin D, Furlan A, Islam S, Abdo H, Lonnerberg P, Lou D,
et al. Unbiased classification of sensory neuron types by
large-scale single-cell RNA sequencing. Nat Neurosci
2015;18:145-53.
21. Zheng Y, Liu P, Bai L, Trimmer JS, Bean BP, Ginty DD.
Deep sequencing of somatosensory neurons reveals molecu-
lar determinants of intrinsic physiological properties. Neuron
2019;103:598-616.e7.
22. Li L, Rutlin M, Abraira VE, Cassidy C, Kus L, Gong S, et al.
The functional organization of cutaneous low-threshold
mechanosensory neurons. Cell 2011;147:1615-27.
23. Salio C, Aimar P, Malapert P, Moqrich A, Merighi A.
Neurochemical and ultrastructural characterization of
unmyelinated non-peptidergic C-nociceptors and C-low
threshold mechanoreceptors projecting to lamina II of the
mouse spinal cord. Cell Mol Neurobiol 2021;41:247-62.
24. Seal RP, Wang X, Guan Y, Raja SN, Woodbury CJ, Basbaum
AI, et al. Injury-induced mechanical hypersensitivity requires
C-low threshold mechanoreceptors. Nature 2009;462:651-5.
25. Delfini MC, Mantilleri A, Gaillard S, Hao J, Reynders A,
Malapert P, et al. TAFA4, a chemokine-like protein, modu-
lates injury-induced mechanical and chemical pain hypersen-
sitivity in mice. Cell Rep 2013;5:378-88.
26. Kambrun C, Roca-Lapirot O, Salio C, Landry M, Moqrich A,
Le Feuvre Y. TAFA4 reverses mechanical allodynia through
activation of GABAergic transmission and microglial
process retraction. Cell Rep 2018;22:2886-97.
27. Gaillard S, Lo Re L, Mantilleri A, Hepp R, Urien L, Malapert
P, et al. GINIP, a Galphai-interacting protein, functions as a
key modulator of peripheral GABAB receptor-mediated
[page 53][European Journal of Histochemistry 2021; 65(s1):3276]
2021_s 1 Article.qxp_Hrev_master  19/10/21  09:12  Pagina 53
                             Review
analgesia. Neuron 2014;84:123-36.
28. Liu Z, Wang F, Fischer G, Hogan QH, Yu H. Peripheral nerve
injury induces loss of nociceptive neuron-specific Galphai-
interacting protein in neuropathic pain rat. Mol Pain
2016;12:1744806916646380.
29. Cavanaugh DJ, Chesler AT, Braz JM, Shah NM, Julius D,
Basbaum AI. Restriction of transient receptor potential vanil-
loid-1 to the peptidergic subset of primary afferent neurons
follows its developmental downregulation in nonpeptidergic
neurons. J Neurosci 2011;31:10119-27.
30. Wang J, La JH, Hamill OP. PIEZO1 is selectively expressed
in small diameter mouse DRG neurons distinct from neurons
strongly expressing TRPV1. Front Mol Neurosci
2019;12:178.
31. Beaulieu-Laroche L, Christin M, Donoghue A, Agosti F,
Yousefpour N, Petitjean H, et al. TACAN is an ion channel
involved in sensing mechanical pain. Cell 2020;180:956-
67.e17.
32. Wang F, Belanger E, Cote SL, Desrosiers P, Prescott SA,
Cote DC, et al. Sensory afferents use different coding strate-
gies for heat and cold. Cell Rep 2018;23:2001-13.
33. Guo A, Vulchanova L, Wang J, Li X, Elde R.
Immunocytochemical localization of the vanilloid receptor 1
(VR1): relationship to neuropeptides, the P2X3 purinoceptor
and IB4 binding sites. Eur J Neurosci 1999;11:946-58.
34. Hwang SJ, Oh JM, Valtschanoff JG. Expression of the vanil-
loid receptor TRPV1 in rat dorsal root ganglion neurons sup-
ports different roles of the receptor in visceral and cutaneous
afferents. Brain Res 2005;1047:261-6.
35. Michael GJ, Priestley JV. Differential expression of the
mRNA for the vanilloid receptor subtype 1 in cells of the
adult rat dorsal root and nodose ganglia and its downregula-
tion by axotomy. J Neurosci 1999;19:1844-54.
36. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert
H, Skinner K, et al. The cloned capsaicin receptor integrates
multiple pain-producing stimuli. Neuron 1998;21:531-43.
37. Woodbury CJ, Zwick M, Wang S, Lawson JJ, Caterina MJ,
Koltzenburg M, et al. Nociceptors lacking TRPV1 and
TRPV2 have normal heat responses. J Neurosci
2004;24:6410-5.
38. Breese NM, George AC, Pauers LE, Stucky CL. Peripheral
inflammation selectively increases TRPV1 function in IB4-
positive sensory neurons from adult mouse. Pain
2005;115:37-49.
39. Zwick M, Davis BM, Woodbury CJ, Burkett JN, Koerber
HR, Simpson JF, et al. Glial cell line-derived neurotrophic
factor is a survival factor for isolectin B4-positive, but not
vanilloid receptor 1-positive, neurons in the mouse. J
Neurosci 2002;22:4057-65.
40. Reynders A, Moqrich A. Analysis of cutaneous MRGPRD
free nerve endings and C-LTMRs transcriptomes by RNA-
sequencing. Genom Data 2015;5:132-5.
41. Shiers SI, Sankaranarayanan I, Jeevakumar V, Cervantes A,
Reese JC, Price TJ. Convergence of peptidergic and non-pep-
tidergic protein markers in the human dorsal root ganglion
and spinal dorsal horn. J Comp Neurol 2021;529:2771-88.
42. Cavanaugh DJ, Lee H, Lo L, Shields SD, Zylka MJ,
Basbaum AI, et al. Distinct subsets of unmyelinated primary
sensory fibers mediate behavioral responses to noxious ther-
mal and mechanical stimuli. Proc Natl Acad Sci USA
2009;106:9075-80.
43. Ferrini F, Perez-Sanchez J, Ferland S, Lorenzo LE, Godin
AG, Plasencia-Fernandez I, et al. Differential chloride home-
ostasis in the spinal dorsal horn locally shapes synaptic meta-
plasticity and modality-specific sensitization. Nat Commun
2020;11:3935.
44. Hanani M. Satellite glial cells in sensory ganglia: from form
to function. Brain Res Brain Res Rev 2005;48:457-76.
45. Huang LY, Gu Y, Chen Y. Communication between neuronal
somata and satellite glial cells in sensory ganglia. Glia
2013;61:1571-81.
46. Pannese E. The satellite cells of the sensory ganglia. Adv
Anat Embryol Cell Biol 1981;65:1-111.
47. Pannese E, Ledda M, Arcidiacono G, Rigamonti L. Clusters
of nerve cell bodies enclosed within a common connective
tissue envelope in the spinal ganglia of the lizard and rat. Cell
Tissue Res 1991;264:209-14.
48. Hanani M, Spray DC. Emerging importance of satellite glia
in nervous system function and dysfunction. Nat Rev
Neurosci 2020;21:485-98.
49. Ledda M, De Palo S, Pannese E. Ratios between number of
neuroglial cells and number and volume of nerve cells in the
spinal ganglia of two species of reptiles and three species of
mammals. Tissue Cell 2004;36:55-62.
50. Pannese E, Procacci P, Ledda M, Conte V. Age-related reduc-
tion of the satellite cell sheath around spinal ganglion neu-
rons in the rabbit. J Neurocytol 1996;25:137-46.
51. Ciglieri E, Vacca M, Ferrini F, Atteya MA, Aimar P, Ficarra
E, et al. Cytoarchitectural analysis of the neuron-to-glia asso-
ciation in the dorsal root ganglia of normal and diabetic mice.
J Anat 2020;237:988-97.
52. Manteniotis S, Lehmann R, Flegel C, Vogel F, Hofreuter A,
Schreiner BS, et al. Comprehensive RNA-Seq expression
analysis of sensory ganglia with a focus on ion channels and
GPCRs in Trigeminal ganglia. PLoS One 2013;8:e79523.
53. Procacci P, Magnaghi V, Pannese E. Perineuronal satellite
cells in mouse spinal ganglia express the gap junction protein
connexin43 throughout life with decline in old age. Brain Res
Bull 2008;75:562-9.
54. Huang TY, Cherkas PS, Rosenthal DW, Hanani M. Dye cou-
pling among satellite glial cells in mammalian dorsal root
ganglia. Brain Res 2005;1036:42-9.
55. Weick M, Cherkas PS, Hartig W, Pannicke T, Uckermann O,
Bringmann A, et al. P2 receptors in satellite glial cells in
trigeminal ganglia of mice. Neuroscience 2003;120:969-77.
56. Li L, Zhou XF. Pericellular Griffonia simplicifolia I isolectin
B4-binding ring structures in the dorsal root ganglia follow-
ing peripheral nerve injury in rats. J Comp Neurol
2001;439:259-74.
57. Woodham P, Anderson PN, Nadim W, Turmaine M. Satellite
cells surrounding axotomised rat dorsal root ganglion cells
increase expression of a GFAP-like protein. Neurosci Lett
1989;98:8-12.
58. Nascimento RS, Santiago MF, Marques SA, Allodi S,
Martinez AM. Diversity among satellite glial cells in dorsal
root ganglia of the rat. Braz J Med Biol Res 2008;41:1011-7.
59. Sandelin M, Zabihi S, Liu L, Wicher G, Kozlova EN. Metastasis-
associated S100A4 (Mts1) protein is expressed in subpopulations
of sensory and autonomic neurons and in Schwann cells of the
adult rat. J Comp Neurol 2004;473:233-43.
60. Vit JP, Ohara PT, Bhargava A, Kelley K, Jasmin L. Silencing
the Kir4.1 potassium channel subunit in satellite glial cells of
the rat trigeminal ganglion results in pain-like behavior in the
absence of nerve injury. J Neurosci 2008;28:4161-71.
61. Keast JR, Stephensen TM. Glutamate and aspartate
immunoreactivity in dorsal root ganglion cells supplying vis-
ceral and somatic targets and evidence for peripheral axonal
transport. J Comp Neurol 2000;424:577-87.
62. Devor M, Wall PD. Cross-excitation in dorsal root ganglia of
nerve-injured and intact rats. J Neurophysiol 1990;64:1733-46.
[page 54]                                         [European Journal of Histochemistry 2021; 65(s1):3276]
2021_s 1 Article.qxp_Hrev_master  19/10/21  09:12  Pagina 54
                                                                                                                   Review
63. Rozanski GM, Kim H, Li Q, Wong FK, Stanley EF. Slow
chemical transmission between dorsal root ganglion neuron
somata. Eur J Neurosci 2012;36:3314-21.
64. Rozanski GM, Li Q, Stanley EF. Transglial transmission at
the dorsal root ganglion sandwich synapse: glial cell to post-
synaptic neuron communication. Eur J Neurosci
2013;37:1221-8.
65. Belzer V, Hanani M. Nitric oxide as a messenger between
neurons and satellite glial cells in dorsal root ganglia. Glia
2019;67:1296-307.
66. Hanz S, Fainzilber M. Retrograde signaling in injured nerve-
-the axon reaction revisited. J Neurochem 2006;99:13-9.
67. Scheib J, Hoke A. Advances in peripheral nerve regeneration.
Nat Rev Neurol 2013;9:668-76.
68. Jortner BS. Common structural lesions of the peripheral
nervous system. Toxicol Pathol 2020;48:96-104.
69. Carozzi VA, Canta A, Oggioni N, Sala B, Chiorazzi A,
Meregalli C, et al. Neurophysiological and neuropathological
characterization of new murine models of chemotherapy-
induced chronic peripheral neuropathies. Exp Neurol
2010;226:301-9.
70. Figliuzzi M, Bianchi R, Cavagnini C, Lombardi R, Porretta-
Serapiglia C, Lauria G, et al. Islet transplantation and insulin
administration relieve long-term complications and rescue
the residual endogenous pancreatic beta cells. Am J Pathol
2013;183:1527-38.
71. Goncalves NP, Vaegter CB, Andersen H, Ostergaard L,
Calcutt NA, Jensen TS. Schwann cell interactions with axons
and microvessels in diabetic neuropathy. Nat Rev Neurol
2017;13:135-47.
72. Roman-Pintos LM, Villegas-Rivera G, Rodriguez-Carrizalez
AD, Miranda-Diaz AG, Cardona-Munoz EG. Diabetic
polyneuropathy in type 2 diabetes mellitus: Inflammation,
oxidative stress, and mitochondrial function. J Diabetes Res
2016;2016:3425617.
73. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann
JA, Mentzer A, et al. High glucose-induced oxidative stress
and mitochondrial dysfunction in neurons. FASEB J
2002;16:1738-48.
74. Schmeichel AM, Schmelzer JD, Low PA. Oxidative injury
and apoptosis of dorsal root ganglion neurons in chronic
experimental diabetic neuropathy. Diabetes 2003;52:165-71.
75. Othman A, Bianchi R, Alecu I, Wei Y, Porretta-Serapiglia C,
Lombardi R, et al. Lowering plasma 1-deoxysphingolipids
improves neuropathy in diabetic rats. Diabetes 2015;64:
1035-45.
76. Zhang Q, Song W, Zhao B, Xie J, Sun Q, Shi X, et al.
Quercetin attenuates diabetic peripheral neuropathy by cor-
recting mitochondrial abnormality via activation of
AMPK/PGC-1alpha pathway in vivo and in vitro. Front
Neurosci 2021;15:636172.
77. Frias B, Merighi A. Capsaicin, nociception and pain.
Molecules 2016;21:797.
78. Moran MM, McAlexander MA, Biro T, Szallasi A. Transient
receptor potential channels as therapeutic targets. Nat Rev
Drug Discov 2011;10:601-20.
79. Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid
receptor TRPV1: 10 years from channel cloning to antagonist
proof-of-concept. Nat Rev Drug Discov 2007;6:357-72.
80. Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors
and mechanisms. Pharmacol Rev 1999;51:159-212.
81. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA,
Levine JD, Julius D. The capsaicin receptor: a heat-activated
ion channel in the pain pathway. Nature 1997;389:816-24.
82. Quartu M, Carozzi VA, Dorsey SG, Serra MP, Poddighe L,
Picci C, et al. Bortezomib treatment produces nocifensive
behavior and changes in the expression of TRPV1, CGRP,
and substance P in the rat DRG, spinal cord, and sciatic
nerve. Biomed Res Int 2014;2014:180428.
83. Fenzi F, Benedetti MD, Moretto G, Rizzuto N. Glial cell and
macrophage reactions in rat spinal ganglion after peripheral
nerve lesions: an immunocytochemical and morphometric
study. Arch Ital Biol 2001;139:357-65.
84. Muratori L, Ronchi G, Raimondo S, Geuna S, Giacobini-
Robecchi MG, Fornaro M. Generation of new neurons in dor-
sal root Ganglia in adult rats after peripheral nerve crush
injury. Neural Plast 2015;2015:860546.
85. Pannese E. Number and structure of perisomatic satellite
cells of spinal ganglia under normal conditions or during
axon regeneration and neuronal hypertrophy. Z Zellforsch
Mikrosk Anat 1964;63:568-92.
86. Takeda M, Tanimoto T, Kadoi J, Nasu M, Takahashi M,
Kitagawa J, et al. Enhanced excitability of nociceptive
trigeminal ganglion neurons by satellite glial cytokine fol-
lowing peripheral inflammation. Pain 2007;129:155-66.
87. Xian CJ, Zhou XF. Neuronal-glial differential expression of
TGF-alpha and its receptor in the dorsal root ganglia in
response to sciatic nerve lesion. Exp Neurol 1999;157:317-26.
88. Zhang Y, Roslan R, Lang D, Schachner M, Lieberman AR,
Anderson PN. Expression of CHL1 and L1 by neurons and
glia following sciatic nerve and dorsal root injury. Mol Cell
Neurosci 2000;16:71-86.
89. Zhou XF, Rush RA, McLachlan EM. Differential expression
of the p75 nerve growth factor receptor in glia and neurons of
the rat dorsal root ganglia after peripheral nerve transection.
J Neurosci 1996;16:2901-11.
90. Pannese E, Ledda M, Cherkas PS, Huang TY, Hanani M.
Satellite cell reactions to axon injury of sensory ganglion
neurons: increase in number of gap junctions and formation
of bridges connecting previously separate perineuronal
sheaths. Anat Embryol (Berl) 2003;206:337-47.
91. Hanani M, Huang TY, Cherkas PS, Ledda M, Pannese E.
Glial cell plasticity in sensory ganglia induced by nerve dam-
age. Neuroscience 2002;114:279-83.
92. Di Cesare Mannelli L, Pacini A, Micheli L, Tani A,
Zanardelli M, Ghelardini C. Glial role in oxaliplatin-induced
neuropathic pain. Exp Neurol 2014;261:22-33.
93. Warwick RA, Hanani M. The contribution of satellite glial
cells to chemotherapy-induced neuropathic pain. Eur J Pain
2013;17:571-80.
94. Hanani M. Intercellular communication in sensory ganglia by
purinergic receptors and gap junctions: implications for
chronic pain. Brain Res 2012;1487:183-91.
95. Carozzi VA, Renn CL, Bardini M, Fazio G, Chiorazzi A,
Meregalli C, et al. Bortezomib-induced painful peripheral
neuropathy: an electrophysiological, behavioral, morpholog-
ical and mechanistic study in the mouse. PLoS One
2013;8:e72995.
96. Cece R, Petruccioli MG, Pizzini G, Cavaletti G, Tredici G.
Ultrastructural aspects of DRG satellite cell involvement in
experimental cisplatin neuronopathy. J Submicrosc Cytol
Pathol 1995;27:417-25.
97. Abdelhak A, Huss A, Kassubek J, Tumani H, Otto M. Serum
GFAP as a biomarker for disease severity in multiple sclero-
sis. Sci Rep 2018;8:14798.
98. Hanani M, Blum E, Liu S, Peng L, Liang S. Satellite glial
cells in dorsal root ganglia are activated in streptozotocin-
treated rodents. J Cell Mol Med 2014;18:2367-71.
99. Nascimento DS, Castro-Lopes JM, Moreira Neto FL.
Satellite glial cells surrounding primary afferent neurons are
[page 55][European Journal of Histochemistry 2021; 65(s1):3276]
2021_s 1 Article.qxp_Hrev_master  19/10/21  09:12  Pagina 55
                             Review
activated and proliferate during monoarthritis in rats: is there
a role for ATF3? PLoS One 2014;9:e108152.
100. Schindler CR, Lustenberger T, Woschek M, Stormann P,
Henrich D, Radermacher P, et al. Severe traumatic brain
injury (TBI) modulates the kinetic profile of the inflammato-
ry response of markers for neuronal damage. J Clin Med
2020;9:1667.
101. Yuan Q, Liu X, Xian YF, Yao M, Zhang X, Huang P, et al.
Satellite glia activation in dorsal root ganglion contributes to
mechanical allodynia after selective motor fiber injury in
adult rats. Biomed Pharmacother 2020;127:110187.
102. Adaes S, Almeida L, Potes CS, Ferreira AR, Castro-Lopes
JM, Ferreira-Gomes J, et al. Glial activation in the collage-
nase model of nociception associated with osteoarthritis. Mol
Pain 2017;13:1744806916688219.
103. Barragan-Iglesias P, Oidor-Chan VH, Loeza-Alcocer E,
Pineda-Farias JB, Velazquez-Lagunas I, Salinas-Abarca AB,
et al. Evaluation of the neonatal streptozotocin model of dia-
betes in rats: Evidence for a model of neuropathic pain.
Pharmacol Rep 2018;70:294-303.
104. Peters CM, Jimenez-Andrade JM, Kuskowski MA, Ghilardi
JR, Mantyh PW. An evolving cellular pathology occurs in
dorsal root ganglia, peripheral nerve and spinal cord follow-
ing intravenous administration of paclitaxel in the rat. Brain
Res 2007;1168:46-59.
105. Kalynovska N, Diallo M, Sotakova-Kasparova D, Palecek J.
Losartan attenuates neuroinflammation and neuropathic pain
in paclitaxel-induced peripheral neuropathy. J Cell Mol Med
2020;24:7949-58.
106. Zhang H, Li Y, de Carvalho-Barbosa M, Kavelaars A,
Heijnen CJ, Albrecht PJ, et al. Dorsal root ganglion infiltra-
tion by macrophages contributes to paclitaxel chemotherapy-
induced peripheral neuropathy. J Pain 2016;17:775-86.
107. Hu P, McLachlan EM. Macrophage and lymphocyte invasion
of dorsal root ganglia after peripheral nerve lesions in the rat.
Neuroscience 2002;112:23-38.
108. Xie WR, Deng H, Li H, Bowen TL, Strong JA, Zhang JM.
Robust increase of cutaneous sensitivity, cytokine production
and sympathetic sprouting in rats with localized inflammato-
ry irritation of the spinal ganglia. Neuroscience
2006;142:809-22.
109. Kamiya H, Zhang W, Sima AA. Degeneration of the Golgi
and neuronal loss in dorsal root ganglia in diabetic
BioBreeding/Worcester rats. Diabetologia 2006;49:2763-74.
110. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN,
Feldman EL. Neurons undergo apoptosis in animal and cell
culture models of diabetes. Neurobiol Dis 1999;6:347-63.
111. Scuteri A, Galimberti A, Maggioni D, Ravasi M, Pasini S,
Nicolini G, et al. Role of MAPKs in platinum-induced neu-
ronal apoptosis. Neurotoxicology 2009;30:312-9.
112. Bobylev I, Joshi AR, Barham M, Neiss WF, Lehmann HC.
Depletion of mitofusin-2 causes mitochondrial damage in cis-
platin-induced neuropathy. Mol Neurobiol 2018;55:1227-35.
113. Canta A, Pozzi E, Carozzi VA. Mitochondrial dysfunction in
chemotherapy-induced peripheral neuropathy (CIPN). Toxics
2015;3:198-223.
114. Leo M, Schmitt LI, Kusterarent P, Kutritz A, Rassaf T,
Kleinschnitz C, et al. Platinum-based drugs cause mitochon-
drial dysfunction in cultured dorsal root ganglion neurons. Int
J Mol Sci 2020;21:8636.
115. McDonald ES, Randon KR, Knight A, Windebank AJ.
Cisplatin preferentially binds to DNA in dorsal root ganglion
neurons in vitro and in vivo: a potential mechanism for neu-
rotoxicity. Neurobiol Dis 2005;18:305-13.
116. Ta LE, Espeset L, Podratz J, Windebank AJ. Neurotoxicity of
oxaliplatin and cisplatin for dorsal root ganglion neurons cor-
relates with platinum-DNA binding. Neurotoxicology
2006;27:992-1002.
117. Podratz JL, Knight AM, Ta LE, Staff NP, Gass JM, Genelin
K, et al. Cisplatin induced mitochondrial DNA damage in
dorsal root ganglion neurons. Neurobiol Dis 2011;41:661-8.
118. Corsetti G, Rodella L, Rezzani R, Stacchiotti A, Bianchi R.
Cytoplasmic changes in satellite cells of spinal ganglia
induced by cisplatin treatment in rats. Ultrastruct Pathol
2000;24:259-65.
119. Garrett FG, Durham PL. Differential expression of connexins
in trigeminal ganglion neurons and satellite glial cells in
response to chronic or acute joint inflammation. Neuron Glia
Biol 2008;4:295-306.
120. Ohara PT, Vit JP, Bhargava A, Jasmin L. Evidence for a role
of connexin 43 in trigeminal pain using RNA interference in
vivo. J Neurophysiol 2008;100:3064-73.
121. Verkhratsky A, Fernyhough P. Calcium signalling in sensory
neurones and peripheral glia in the context of diabetic neu-
ropathies. Cell Calcium 2014;56:362-71.
122. Liu S, Zou L, Xie J, Xie W, Wen S, Xie Q, et al. LncRNA
NONRATT021972 siRNA regulates neuropathic pain behav-
iors in type 2 diabetic rats through the P2X7 receptor in dor-
sal root ganglia. Mol Brain 2016;9:44.
123. Porter DDL, Morton PD. Clearing techniques for visualizing
the nervous system in development, injury, and disease. J
Neurosci Methods 2020;334:108594.
124. Ueda HR, Dodt HU, Osten P, Economo MN, Chandrashekar
J, Keller PJ. Whole-brain profiling of cells and circuits in
mammals by tissue clearing and light-sheet microscopy.
Neuron 2020;106:369-87.
125. Ahnfelt-Ronne J, Jorgensen MC, Hald J, Madsen OD, Serup
P, Hecksher-Sorensen J. An improved method for three-
dimensional reconstruction of protein expression patterns in
intact mouse and chicken embryos and organs. J Histochem
Cytochem 2007;55:925-30.
126. Renier N, Wu Z, Simon DJ, Yang J, Ariel P, Tessier-Lavigne
M. iDISCO: a simple, rapid method to immunolabel large tis-
sue samples for volume imaging. Cell 2014;159:896-910.
127. West SJ, Bennett DL. StereoMate: A stereological and auto-
mated analysis platform for assessing histological labelling
in cleared tissue specimens. bioRxiv 2019:648337.
128. Chung K, Deisseroth K. CLARITY for mapping the nervous
system. Nat Methods 2013;10:508-13.
129. Yang B, Treweek JB, Kulkarni RP, Deverman BE, Chen CK,
Lubeck E, et al. Single-cell phenotyping within transparent
intact tissue through whole-body clearing. Cell
2014;158:945-58.
130. Bernal L, Cisneros E, Garcia-Magro N, Roza C.
Immunostaining in whole-mount lipid-cleared peripheral
nerves and dorsal root ganglia after neuropathy in mice. Sci
Rep 2019;9:8374.
131. Ciglieri E, Ferrini F, Boggio E, Salio C. An improved method
for in vitro morphofunctional analysis of mouse dorsal root
ganglia. Ann Anat 2016;207:62-7.
132. Hayar A, Gu C, Al-Chaer ED. An improved method for patch
clamp recording and calcium imaging of neurons in the intact
dorsal root ganglion in rats. J Neurosci Methods
2008;173:74-82.
133. Zhang JM, Donnelly DF, LaMotte RH. Patch clamp record-
ing from the intact dorsal root ganglion. J Neurosci Methods
1998;79:97-103.
134. Tomer R, Ye L, Hsueh B, Deisseroth K. Advanced CLARITY
for rapid and high-resolution imaging of intact tissues. Nat
Protoc 2014;9:1682-97.
[page 56]                                         [European Journal of Histochemistry 2021; 65(s1):3276]
2021_s 1 Article.qxp_Hrev_master  19/10/21  09:12  Pagina 56
                                                                                                                   Review
135. Quinta HR, Pasquini LA, Pasquini JM. Three-dimensional
reconstruction of corticospinal tract using one-photon confo-
cal microscopy acquisition allows detection of axonal disrup-
tion in spinal cord injury. J Neurochem 2015;133:113-24.
136. Di Cataldo S, Tonti S, Ciglieri E, Ferrini F, Macii E, Ficarra
E, et al. Automated 3D immunofluorescence analysis of dor-
sal root ganglia for the investigation of neural circuit alter-
ations: a preliminary study. Ann Comp Sci Inform Syst
2016;9:65-70.
137. Piccinini F, Balassa T, Carbonaro A, Diosdi A, Toth T,
Moshkov N, et al. Software tools for 3D nuclei segmentation
and quantitative analysis in multicellular aggregates. Comput
Struct Biotechnol J 2020;18:1287-300.
138. Ferrini F, Russo A, Salio C. Fos and pERK immunoreactivity
in spinal cord slices: Comparative analysis of in vitro models
for testing putative antinociceptive molecules. Ann Anat
2014;196:217-23.
[page 57][European Journal of Histochemistry 2021; 65(s1):3276]
Received for publication: 26 May 2021. Accepted for publication: 16 August 2021.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
©Copyright: the Author(s), 2021
Licensee PAGEPress, Italy
European Journal of Histochemistry 2021; 65(s1):3276
doi:10.4081/ejh.2021.3276
2021_s 1 Article.qxp_Hrev_master  19/10/21  09:12  Pagina 57
